From the Editor-in-Chief

Shorter, more intense radiation regimens may be as effective as traditional treatments, with greater convenience for patients.

by William G. Nelson, MD, PhD

Forward Look

Epidemiologist Scarlett Lin Gomez explains how a new study aims to better understand cancer risk among Asian Americans.

by Kris Conner

Forward Look

An experimental antibody helped people recover body mass lost due to cancer and treatment.

by Darcy Lewis

Forward Look

Patients who received Opdivo and chemotherapy had better outcomes and fewer side effects than those who had the standard-of-care therapy.

by Susan Kreimer

Forward Look

Saliva test can help identify people who are at high risk of recurrence after mouth or throat cancer treatment.

by Eric Fitzsimmons

Forward Look

Researchers analyze whether giving immunotherapy before surgery benefits people with high-risk disease that is limited to the liver.

by Christina Szalinski

Forward Look

Study underscores importance of regular hearing tests for those who receive cisplatin chemotherapy.

by Risa Kerslake

Policy Matters

A forthcoming article series outlines considerations for the dose optimization of modern oncology drugs.

by Brad Davidson, PhD

People with metastatic hormone receptor-positive breast cancer are living longer, thanks to new targeted therapies and endocrine therapies that can be prescribed when treatment resistance develops.

by Kendall K. Morgan

Blood tests can guide treatment choices, delivering results in less time than traditional biopsies.

by Stephen Ornes